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Despite the general consensus that synaesthesia emerges at an early developmental
stage and is only rarely acquired during adulthood, the transient induction of synaesthesia
with chemical agents has been frequently reported in research on different psychoactive
substances. Nevertheless, these effects remain poorly understood and have not been
systematically incorporated. Here we review the known published studies in which
chemical agents were observed to elicit synaesthesia. Across studies there is consistent
evidence that serotonin agonists elicit transient experiences of synaesthesia. Despite
convergent results across studies, studies investigating the induction of synaesthesia
with chemical agents have numerous methodological limitations and little experimental
research has been conducted. Cumulatively, these studies implicate the serotonergic
system in synaesthesia and have implications for the neurochemical mechanisms
underlying this phenomenon but methodological limitations in this research area preclude
making firm conclusions regarding whether chemical agents can induce genuine
synaesthesia.
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INTRODUCTION
Synaesthesia is an unusual condition in which a stimulus will
consistently and involuntarily produce a second concurrent
experience (Ward, 2013). An example includes grapheme-color
synaesthesia, in which letters and numerals will involuntarily
elicit experiences of color. There is emerging evidence that synaes-
thesia has a genetic basis (Brang and Ramachandran, 2011), but
that the specific associations that an individual experiences are
in part shaped by the environment (e.g., Witthoft and Winawer,
2013). Further research suggests that synaesthesia emerges at
an early developmental stage, but there are isolated cases of
adult-onset synaesthesia (Ro et al., 2007) and it remains unclear
whether genuine synaesthesia can be induced in non-synaesthetes
(Terhune et al., 2014).
Despite the consensus regarding the developmental origins
of synaesthesia, the transient induction of synaesthesia with
chemical agents has been known about since the beginning
of scientific research on psychedelic drugs (e.g., Ellis, 1898).
Since this time, numerous observations attest to a wide range
of psychoactive substances that give rise to a range of synaes-
thesias, however, there has been scant systematic quantitative
research conducted to explore this phenomenon, leaving some-
what of a lacuna in our understanding of the neurochemical
factors involved and whether such phenomena constitute gen-
uine synaesthesia. A number of recent theories of synaesthesia
implicate particular neurochemicals and thus the possible phar-
macological induction of synaesthesia may lend insights into the
neurochemical basis of this condition. For instance, disinhibition
theories, which propose that synaesthesia arises from a disrup-
tion in inhibitory activity, implicate attenuated γ-aminobutyric
acid (GABA) in synaesthesia (Hubbard et al., 2011), whereas
Brang and Ramachandran (2008) have specifically hypothesized
a role for serotonin in synaesthesia. Furthermore, the chemical
induction of synaesthesia may permit investigating experimen-
tal questions that have hitherto been impossible with congenital
synaesthetes (see Terhune et al., 2014).
Despite the potential value in elucidating the induction of
synaesthesia with chemical agents, there is a relative paucity of
research on this topic and a systematic review of the literature
is wanting. There is also an unfortunate tendency in the cogni-
tive neuroscience literature to overstate or understate the possi-
ble induction of synaesthesia with chemical agents. The present
review seeks to fill the gap in this research domain by summa-
rizing research studies investigating the induction of synaesthesia
with chemical agents. Specifically, our review suggests that psy-
choactive substances, in particular those targeting the serotonin
system, may provide a valuable method for studying synaesthesia
under laboratory conditions, but that methodological limitations
in this research domain warrant that we interpret the chemical
induction of synaesthesia with caution.
METHODS
LITERATURE SEARCH AND INCLUSION CRITERIA
A literature search in the English language was conducted using
relevant databases (PubMed, PsychNet, Psychinfo) using the
search terms synaesthesia, synesthesia, drug, psychedelic, LSD,
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psilocybin, mescaline, MDMA, ketamine, and cannabis and by
following upstream the cascade of references found in those arti-
cles. Initially a meta-analysis of quantitative findings was planned,
however, it became apparent that there had been only four direct
experimental attempts to induce synaesthesia in the laboratory
using psychoactive substances, making such an analysis unneces-
sary. A larger number of other papers exist, however, describing
indirect experiments in which participants were administered a
psychoactive substance under controlled conditions and asked via
questionnaire, as part of a battery of phenomenological ques-
tions, if they experienced synaesthesia during the active period of
the drug. Whilst these studies typically provide a non-drug state
condition for comparison they did not set out to induce synaes-
thesia and so are less evidential than direct experimental studies.
There also exist a number of case reports describing the induc-
tion of synaesthesia using chemical agents within various fields of
study. Under this category, we include formal case studies as well
as anecdotal observations. A final group of studies used survey
methodologies, providing information regarding the prevalence
and type of chemically-induced synaesthesias among substance
users outside of the laboratory. Given the range of methodolo-
gies and quality of research, we summarize the studies within the
context of different designs.
DRUG TYPES
The majority of the studies and case reports relate to just
three psychedelic substances—lysergic acid diethylamide (LSD),
mescaline, and psilocybin. However, some data is also available
for ketamine, ayahuasca, MDMA, as well as less common sub-
stances such as 4-HO-MET, ibogaine, Ipomoea purpurea, amyl
nitrate, Salvia divinorum, in addition to the occasional reference
to more commonly used drugs such as alcohol, caffeine, tobacco,
cannabis, fluoxetine, and buproprion.
RESULTS
The final search identified 35 studies, which are summarized in
Table 1. Here we review the most salient results from the different
studies.
EXPERIMENTAL STUDIES
Among experimental studies, we distinguish between direct and
indirect experiments as those that explicitly attempted to induce
synaesthesia in a hypothesis-driven manner and those that
explored the induction of synaesthesia as part of a larger battery,
respectively.
Direct experiments
We identified four published experimental studies formally
attempting to induce synaesthesia with pharmacological agents
(Kelly, 1934; Simpson and McKellar, 1955; Hartman and
Hollister, 1963; Masters and Houston, 1966). In the first study
(Kelly, 1934), four non-synaesthetes had previously taken part
in a 7-week auditory tone-color associative training study in
which they were presented with eight different tone-color pairs
2000 times. Although the participants demonstrated a tone-color
association learning effect, no evidence of spontaneous color pho-
tisms in response to the tones were observed. One week after
the last training session the participants were joined by a fifth
who had the day before received 1000 single tone-color pairings
but likewise demonstrated no synaesthesia, and they consumed
15 g of (presumably dried) peyote cactus. Although not spec-
ified, this amount of peyote provides an estimated dosage of
between 0.15 and 1.2 g of mescaline (Crosby and McLaughlin,
1973; Bruhn et al., 1978), providing anything from a mild to a
very strong dose depending on relative alkaloid content (Shulgin
and Shulgin, 1991). One participant took a further 5 g after receiv-
ing no visual perceptual changes, but to little effect. Although
four of the five participants perceived colorful visual imagery,
due to the mescaline, none perceived the appropriate color
when the tones were played. However, these four participants
experienced other types of synaesthesia, including haptic-visual,
kinaesthetic-visual (especially color), and algesic-color. This sug-
gests a high prevalence of synaesthesia following the consumption
of mescaline, but that mescaline does not seem to enhance trained
associations.
The second study (Simpson and McKellar, 1955), included
two congenital synaesthetes (auditory-visual and multiple types)
with the researchers acting as non-synaesthete controls (McKellar,
1957). Participants were administered four mescaline doses
between 0.3 and 0.5 g (considered strong doses; Shulgin and
Shulgin, 1991) on separate occasions. During the active effects
of the drugs, participants were presented with a variety of
sensory stimuli (visual, auditory, tactile, gustatory, olfactory,
kinaesthetic, thermal, and algesic). Participants reported sev-
eral distinct types of novel synaesthesias: auditory-visual (all 4
participants), kinaesthetic-visual (3), tactile-visual (2), olfactory-
visual (2), algesic-visual (2), thermal-visual (1), olfactory-tactile
(1), visual-tactile (1), and visual-thermal (1), with a relatively
equal ratio of novel synaesthesias (10:7) between synaesthetes and
non-synaesthetes. In addition, one of the congenital synaesthetes
reported enhancement of their usual auditory-tactile and visual-
thermal synaesthesias, suggesting that mescaline can both induce
synaesthesia among non-synaesthetes and enhance synaesthesia
among congenital synaesthetes.
A third study by Hartman and Hollister (1963; see also
Hollister and Hartman, 1962) compared the effects of mescaline
(5mg/kg), psilocybin (150mcg/kg), and LSD (1mcg/kg), con-
sidered to be light to moderate doses, administered under blind
conditions. A total of 18 participants took both substances 1
week apart and received auditory stimulation from 16 pure sonic
tones before and after drug administration. Overall, participants
reported significantly more colors and other auditorily-driven
visual effects (brightening of the visual field, shattering of pat-
terns, and patterning of form) compared to baseline whilst under
the influence of both LSD and mescaline, but not psilocybin,
although there was a non-significant increase in such experiences
with the latter. Fewer than 50% of the participants (exact propor-
tion not reported) experienced auditorily-induced synaesthesia
under the influence of the three psychedelics.
A fourth experimental study is described in Masters and
Houston (1966), but only minimal details about the method-
ology and results were presented. Specifically, they report a
series of informal experiments and interviews conducted with
214 participants in 204 sessions in which psychedelic drugs
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Table 1 | Summary of studies reporting induction or modulation of synaesthesia through drug use.
Author(s) (year) N Study design Stimuli Drug(s) Type(s) of synaesthesia Prevalence of
synaesthesia and
other results
Kelly (1934) 5 Experiment (direct) Pure sonic tones
(previously paired
to colors)
Mescaline Haptic-visual,
kinaesthestic-visual,
algesic-color
80%; No effect of
tone-color training
Hartman and
Hollister (1963)a
Hollister and
Hartman (1962)
18 Experiment (direct) Pure sonic tones Mescaline Auditory-visual 10%; Mescaline >
no drug
Hartman and
Hollister (1963)a
Hollister and
Hartman (1962)
18 Experiment (direct) Pure sonic tones LSD Auditory-visual 15%; LSD > no
drug
Hartman and
Hollister (1963)a
Hollister and
Hartman (1962)
18 Experiment (direct) Pure sonic tones Psilocybin Auditory-visual 11%
Masters and
Houston (1966)
Experiment (direct) Objects LSD Music-visual,
color-gustatory,
color-auditory,
auditory-gustatory,
music-olfactory
Simpson and
McKellar (1955)
4 Experiment (direct) Various Mescaline Auditory-visual,
kinaesthetic- visual,
tactile-visual,
olfactory-visual,
algesic-visual,
thermal-visual,
olfactory-tactile,
visual-thermal
Enhancement of
congenital
synaesthesia
Addy (2010) 30 Experiment
(indirect)
Ordinary
environment
Salvia divinorum Visual-kinaethetic/propi-
oceptive/somatic/tactile
57% (all types),
23%
(visual>tactile)
de Rios and Janiger
(2003)
930 Experiment
(indirect)
LSD Auditory-visual, auditory-
color-tactile-kinaesthetic-
emotion-concept
Carhart-Harris et al.
(2011)
9 Experiment
(indirect)
Ordinary
environment
Psilocybin Auditory-visual
Lahti et al. (2001) 18 Experiment
(indirect)
Ketamine
Riba et al. (2004) 18 Experiment
(indirect)
Ayahuasca Auditory-visual 28%
Savage et al. (1969) 22 Experiment
(indirect)
Ipomoea purpurea
Studerus et al.
(2010)
327 Experiment
(indirect)
Psilocybin Auditory-visual 37%
Studerus et al.
(2010)
102 Experiment
(indirect)
MDMA Auditory-visual 10%
(Continued)
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Table 1 | Continued
Author(s) (year) N Study design Stimuli Drug(s) Type(s) of synaesthesia Prevalence of
synaesthesia and
other results
Studerus et al.
(2010)
162 Experiment
(indirect)
Ketamine Auditory-visual 27%
Studerus et al.
(2011)
110 Experiment
(indirect)
Psilocybin Auditory-visual Linear,
dose-dependent
induced
synaesthesia
Studerus et al.
(2012)
261 Experiment
(indirect)
Psilocybin Auditory-visual Induced
synaesthesia
predicted by drug
dose, absorption
(Tellegen and
Atkinson, 1974),
alcohol
consumption,
sociability,
emotional
excitability, and
activity
Brang and
Ramachandran
(2008)
2 Case report Fluoxetine Inhibition of
congenital
synaesthesia
Brang and
Ramachandran
(2008)
1 Case report Buproprion Inhibition of
congenital
synaesthesia
Brang and
Ramachandran
(2008)
1 Case report Melatonin Grapheme-color Inducer-concurrent
consistency in
induced
synaesthesia
Breslaw (1961) 1 Case report Various Psilocybin Auditory-olfactory,
color-auditory,
gustatory-semantic
Ahmadi et al. (2011) 1 Case report Visual stimuli Meth-amphetamine Color-voices Inhibited by
electroconvulsive
therapy
Cytowic (1993) 1 Case report Amyl Nitrate Gustatory-tactile Enhancement of
congenital
synaesthesia
Cytowic (1993) 1 Case report Alcohol Gustatory-tactile Enhancement of
congenital
synaesthesia
Cytowic (1993) 1 Case report Amphetamine Gustatory-tactile Attenuation of
congenital
synaesthesia
Cytowic (1993) 1 Case report Alcohol cessation Inhibition of
congenital
synaesthesia
(Continued)
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Table 1 | Continued
Author(s) (year) N Study design Stimuli Drug(s) Type(s) of synaesthesia Prevalence of
synaesthesia and
other results
Cytowic and
Eagleman (2009)
6 Case reports LSD 33% enhanced
Fotiou (2012)
1 Case report Music Ayahuasca Music-visual
Klüver (1966) Case reports Mescaline Auditory-visual,
auditory-tactile,
visual-tactile,
color-gustatory,
visual-auditory,
concept-olfactory,
auditory-somatic,
visual-somatic,
auditory-shape,
auditory-tactile,
visual-tactile,
visual-thermal,
haptic-visual,
auditory-visual-somatic,
auditory-visual-somatic-
algesic,
visual-tactile-conceptual-
visual-gustatory-
olfactory-entoptic
La Barre (1975) Case report Mescaline Visual-auditory
McKellar (1957) 1 Case report Mescaline Auditory-gustatory
Marks (1975) Case reports Cannabis and LSD Auditory-visual
McKenna (1982) 1 Case report LSD Auditory-shape
Pahnke and
Richards (1966)
Case reports LSD Music-color
Popik et al. (1995) Case reports Ibogaine Auditory, olfactory and
gustatory
Smythies (1953) Case reports Mescaline Auditory-visual,
auditory-emotion
Hofmann (1983) 1 Case report LSD Auditory-visual
Ward (2008)
1 Case reports LSD Visual-breathing
Shanon (2003) Case reports Ayahuasca Auditory-visual,
olfactory-visual,
tactile-visual
Cytowic and
Eagleman (2009)
1279 Survey Alcohol 9% enhanced, 6%
reduced
(Continued)
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Table 1 | Continued
Author(s) (year) N Study design Stimuli Drug(s) Type(s) of synaesthesia Prevalence of
synaesthesia and
other results
Cytowic and
Eagleman (2009)
1279 Survey Tobacco 1% enhanced, 1%
reduced
Cytowic and
Eagleman (2009)
1279 Survey Caffeine 9% enhanced, 3%
reduced
DeGracia (1995) 62 Survey Multiple psychedelics Auditory-visual,
music-visual,
Visual-auditory,
visual-gustatory,
auditory-somatic,
color-olfactory,
auditory-color,
auditory-shape,
auditory-touch,
auditory-olfactory,
auditory-gustatory,
visual-music,
color-gustatory,
color-auditory,
color-somat,
gustatory-color,
music-touch,
music-somatic,
music-shape,
music-color,
olfactory-gustatory,
olfactory-visual
50% (all types)
Kjellgren and
Soussan (2011)
25 Survey 4-HO-MET Gustatory-auditory and
auditory-visual
Tart (1975) Survey Cannabis Music-color 56% (all types)
Empty cells indicate that the respective information was not reported in the study. aThese two papers describe different analyses from the same data.
were consumed. In the course of this work the authors report
successfully intentionally inducing color-sound and auditory-
gustatory synaesthesia with LSD, but there is no information
regarding the proportion of participants reporting such effects,
the dosage, or other results. Insofar as few details are provided
about this study, it is difficult to critically evaluate its method-
ology and results, but the reported results do converge with the
three previous experimental studies.
These four studies suggest that synaesthesia can be induced
in a controlled environment using chemical agents. Nevertheless,
they suffer from a large number of limitations including a lack
of placebo control, double-blinds, and randomized allocation.
The absence of these experimental controls warrant concerns
about demand characteristics (Orne, 1962)—participants may
have expected to have synaesthesia under the influence of the
drugs, thereby inflating their tendency to endorse that they had
experienced synaesthesia. In addition, the studies identified the
experience of synaesthesia using self-reports rather than behav-
ioral measures of automaticity or consistency (for a review, see
Ward, 2013).
Indirect experiments
Despite the lack of direct experiments in the last 50 years, we iden-
tified nine studies that investigated the psychological effects of
psychedelic drugs under controlled conditions, including placebo
controls. As part of a broad assessment, these studies included
questions regarding the experience of synaesthesia during the
active period of the drug. Studerus (2013) reviews data from
several studies (Studerus et al., 2010, 2011, 2012) that included
nearly 600 psilocybin, MDMA, and ketamine test participants.
Studerus (2013) provides prevalence rates of induced auditory-
visual synaesthesia (only), with sounds as inducers, for these
substances (MDMA: 10%; ketamine: 27%; psilocybin: 37%) and
demonstrates its linear dose-dependent nature with psilocybin,
the most studied substance in this context. Averaged across stud-
ies, the percentage of positive responses to questionnaire items
relating to auditory-visual synaesthesia induced by psilocybin
ranged from 0% for placebo and 45 mcg/kg doses, up to 50%
for the highest psilocybin dose of 315mcg/kg. The linear dose-
synaesthesia relationship with psilocybin is also supported by
independent data on synaesthesia as one of a number of visual
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effects in a similar indirect experiment (Griffiths et al., 2011) and
tallies with earlier reports of less than 50% of participants experi-
encing experimentally-induced auditory-visual synaesthesia with
150mcg/kg of psilocybin (Hartman and Hollister, 1963).
A notable finding of these studies is that psilocybin-
induced auditory-visual synaesthesia is predicted by differ-
ent demographic and individual difference variables, most
notably absorption, the tendency to experience all-encompassing
attentional states characterized by intense affective and imag-
inative involvement in an activity (Tellegen and Atkinson,
1974). Thus, individuals high in absorption appear to be more
prone to drug-induced synaesthesia. Other studies administering
psychedelics experimentally also report the prevalence of synaes-
thesia, usually defined as auditory-visual synaesthesia only. These
studies have found prevalence rates ranging from 10 to 57% with
various substances including ketamine, psilocybin, ayahuasca,
Salvia divinorum, and Ipomoea purpurea, a plant containing LSD-
like alkaloids (Savage et al., 1969; Lahti et al., 2001; Riba et al.,
2004; Addy, 2010; Carhart-Harris et al., 2011).
Indirect experimental studies largely corroborate the results
of the experimental studies. These studies possess a number
of the same limitations, most notably the absence of behav-
ioral measures to corroborate synaesthesia. In addition, they
are exploratory in design and most studies only report on the
prevalence of auditory-visual synaesthesias thereby obscuring our
understanding of the types of synaesthesias induced by the chem-
ical agents studied. However, some of the studies (Lahti et al.,
2001; Riba et al., 2004; Addy, 2010; Carhart-Harris et al., 2011;
Griffiths et al., 2011; Studerus, 2013) benefit from the inclusion of
placebo controls, which in part circumvent confounds pertaining
to demand characteristics.
CASE REPORTS
We identified 17 case reports exploring the apparent induction of
synaesthesia with chemical agents.
The majority of the case studies simply report the form of
synaesthesia that is induced, adding only to the known types that
may be reported (see Table 1 and Figure 1), but a few studies pro-
vide further details regarding phenomenological characteristics of
synaesthesia or information regarding chemical agents that can
modulate congenital synaesthesia. One notable finding among
case reports is Klüver’s (1966) observation of variability in the
perceived visuospatial location of visual concurrents in induced
auditory-color synaesthesia. Specifically, he reported that some
participants would experience concurrents as endogenous men-
tal images or representations whereas others would experience
concurrents as though they were localized in space. This variabil-
ity closely mirrors individual differences among synaesthetes. In
particular, there is evidence that one subset of grapheme-color
synaesthetes experience colors as mental representations (associa-
tors) whereas another experiences colors as spatially co-localized
with the inducing grapheme (projectors) (Dixon et al., 2004; Ward
et al., 2007). Klüver (1966) further noted that mescaline-induced
synaesthesia can sometimes lead to quite complex fusions of
several sensory percepts and may even produce associations
between abstract concepts (e.g., negation) and visual images (e.g.,
a white square metal plate). One case report describes the appar-
ent consistent induction of grapheme-color synaesthesia with
melatonin, the veracity of which was supported with a behavioral
measure of texture segregation (Brang and Ramachandran, 2008).
Of special interest are case reports describing the modula-
tion of congenital synaesthesias with chemical agents. Brang and
Ramachandran (2008) described the inhibition of an unspecified
form of congenital synaesthesia with two types of antidepres-
sant: the selective serotonin reuptake inhibitor, fluoxetine, and
the substituted amphetamine, bupropion. The former result pro-
vides further support for the role of serotonin in the modula-
tion of synaesthesia and thus complements direct and indirect
experimental studies pointing to serotonergic agonists as reliable
inducers of synaesthesia in non-synaesthetes.
As Shanon (2003) notes, case reports of chemically-induced
synaesthesia are typically of the auditory-visual variety, particu-
larly auditory-shape and auditory-color, as occurs with mesca-
line (Smythies, 1953; Klüver, 1966; Marks, 1975), LSD (Pahnke
and Richards, 1966; McKenna, 1982; Hofmann, 1983), cannabis
(Marks, 1975), and ayahuasca (Shanon, 2003; Fotiou, 2012). Such
auditory imagery is sometimes reported to be dynamic in nature
fluctuating with the sounds as they change (e.g., Pahnke and
Richards, 1966; Hofmann, 1983), as when listening to music.
SURVEYS
A small number of surveys report on the prevalence and type
of chemically-induced synaesthesias. These reports are typically
indirect, sampling substance users and reporting on synaesthesia
as one of a number of phenomena occurring under the influ-
ence of different substances. In one study (DeGracia, 1995),
psychedelic substances in general were reported to induce synaes-
thesia in 50% of users with 62 respondents reporting 23 different
types of synaesthesia, the most common of which was auditory-
visual (52% of those reporting synaesthesia), includingmusic and
voice inducers. Similar prevalence rates are found in a survey
of cannabis users (56%) who predominantly reported music-
color synaesthesia (Tart, 1975). Even surveys of users of obscure
psychedelic substances like 4-HO-MET have reported the induc-
tion of synaesthesia, although prevalence rates were not reported
(Kjellgren and Soussan, 2011). Notably, lifetime prevalence of
chemical induction of synaesthesia is relatively higher than for
those induced in individual experimental trials, as might be
expected.
We found one study that surveyed synaesthetes regarding the
impact of chemical agents on congenital synaesthesia (Cytowic
and Eagleman, 2009). This study reports on the relative effects
of commonplace drugs among 1279 verified grapheme-color
synaesthetes. Alcohol and caffeine tended to enhance (9% both
drugs) or reduce (3% caffeine, 6% alcohol) synaesthesia to
relatively comparable degrees. Cytowic and Eagleman (2009)
also report that of six synaesthetes ingesting LSD, two (33%)
reported enhancing effects with the remainder reporting no
effect. Although preliminary, these results suggest that LSD has
stronger effects than commonplace psychoactive substances.
TYPES OF SYNAESTHESIAS
All but a small number of the studies reporting induc-
tion of synaesthesia in non-synaesthetes specified the inducer-
concurrent associations (see Table 1 and Figure 1). The most
commonly reported type was overwhelmingly auditory-visual
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FIGURE 1 | Number of reports of particular inducer-concurrent associations in chemical-induced synaesthesias. Smaller, darker markers reflect fewer
reports.
(19 reports; 23%). In turn, the most frequent inducer was
auditory stimuli including music and voices (39 reports; 47%),
and the most frequent concurrents were visual experiences (43
reports; 52%). However, these figures are somewhat inflated by
the exclusive reporting of auditory-visual synaesthesia in the
indirect experimental studies. Cumulatively, these results suggest
that non-synaesthetes report similar forms of synaesthesia whilst
under the influence of certain drugs as congenital synaesthetes,
but also other inducer-concurrent associations that to our knowl-
edge have not been reported in research studies of congenital
synaesthesia, such as visual-thermal associations.
DISCUSSION
Here we reviewed the known studies describing the apparent
induction and modulation of synaesthesia with chemical agents.
These studies strongly suggest that chemical agents are capable of
producing synaesthesia-like experiences. Crucially, there is large
convergence across studies with different methodologies in terms
of the prevalence of chemical-induced synaesthesia, the types of
drugs (and neurochemical mechanisms) involved, and, to a lesser
extent, the types of synaesthesias reported. There is also prelim-
inary evidence that the same drugs have compatible effects on
congenital synaesthesia. In what follows, we consider the limi-
tations of these studies, the types of chemical agents implicated,
and the types of synaesthesia reported. We conclude by consid-
ering whether these phenomena are comparable to congenital
synaesthesia and offer suggestions for future research.
STUDY LIMITATIONS
Despite the importance of convergent results, this research litera-
ture suffers from a number of substantial limitations, which need
to be considered when interpreting the veracity of the chemi-
cal induction of synaesthesia and any implications this research
has for the neural mechanisms underlying congenital synaes-
thesia. First, there is a relative paucity of experimental studies.
Of these, relatively few included placebo controls and some
may be contaminated by demand characteristics. The absence
of placebo controls in these studies is especially crucial because
there is evidence that various psychedelic drugs enhance sug-
gestibility (for a review, see Whalley and Brooks, 2009) and
thus may augment participants’ susceptibility to demand char-
acteristics. Furthermore, relatively little information is available
regarding dosage, which may be crucial (Studerus, 2013), or the
time course of the phenomenon (i.e., onset and duration). There
is also considerable variability across participants with only a
subset reporting chemical-induced synaesthesia. This variability
may be explained in part by individual differences in absorption
(Studerus, 2013), but has been largely ignored by researchers. The
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majority of the reviewed studies describe case reports and sur-
veys. These types of studies are valuable at suggesting research
avenues and possible mechanisms, but are not sufficiently rig-
orous to enable firm conclusions regarding the veracity of the
effects.
The most severe limitation of the reviewed studies is that all
but one (Brang and Ramachandran, 2008) relied on self-reports
of experiences of synaesthesia. Although reports by congenital
synaesthetes have been consistently validated by behavioral mea-
sures (Ward, 2013), it cannot be assumed that experiential reports
among non-synaesthetes under the influence of chemical agents
would translate to similar behavioral response patterns as congen-
ital synaesthetes. Across studies, synaesthesia may not have been
properly defined to participants or authors may have been using
different definitions. Relatedly, some of the reported forms of
synaesthesia [e.g., semantic-olfactory (Klüver, 1966); gustatory-
semantic, (Breslaw, 1961)] closely resemble states of absorption
(e.g., feeling cold when viewing a picture of an iceberg) (Ott,
2007). Given these limitations, caution must be exerted regarding
the interpretation of the chemical induction of synaesthesia until
these phenomena can be verified using more rigorous behavioral
measures in studies with stronger experimental controls.
TYPES OF CHEMICAL AGENTS
The studies reviewed here suggest that a wide range of drugs can
produce synaesthesia-like experiences, even in controlled settings.
Most of the research has included LSD, mescaline, psilocybin,
ayahuasca, or MDMA. A notable commonality among these sub-
stances is that they are all serotonin agonists (e.g., Nichols, 2004),
specifically serotonin 2A subtype agonists, although some non-
serotonergic substances have been reported to induce synaesthe-
sia, such as ketamine (Lahti et al., 2001) and Salvia divinorum
(Addy, 2010). Few studies have included rigorous comparisons
of these different drug classes, but the available evidence sug-
gests that the prevalence rates for synaesthesia under the influence
of serotonin agonists is greater than for drugs that do not tar-
get serotonin (Luke et al., 2012; Studerus, 2013). Furthermore,
Simpson and McKellar (1955) reported that serotonin agonists
both induced synaesthesia in non-synaesthetes and enhanced
existing synaesthesias in congenital synaesthetes. This result was
recently replicated in a survey of psychedelic users and congenital
synaesthetes (Luke et al., 2012). Cytowic and Eagleman (2009)
also reported the enhancement of congenital synaesthesia with
LSD. Cumulatively, these results clearly implicate serotonin in
synaesthesia and warrant further research on the role of this
neurochemical in synaesthesia.
Nevertheless, other non-serotonergic compounds can also
induce synaesthesia, although the most prevalent ones are typ-
ically also psychedelic in character, such as ketamine, Salvia
divinorum, cannabis, nitrous oxide, datura, and dextromethor-
phan (Tart, 1975; Lahti et al., 2001; Addy, 2010; Luke et al., 2012;
Studerus, 2013). These divergent chemical compounds act pri-
marily on different neurochemical systems to each other and
yet they all elicit profound changes in consciousness and some-
what similar phenomenological syndromes, such as the experi-
ence of synaesthesia. Given that there are currently around 350
known psychedelic chemicals and potentially 2000 untested ones
(Luke, 2012), all with different modes of action, understand-
ing exactly what neurochemical processes are responsible for
the different experiential effects is a complex conundrum that
remains to be disentangled by psychopharmacologists (Presti,
2011). Nevertheless, systemic taxonomical research that relates
specific chemicals to particular experiences could illuminate the
neurochemistry involved (Luke et al., 2012).
TYPES OF SYNAESTHESIA
There was consistent evidence across studies that auditory-visual
synaesthesia was themost commonly experienced form of synaes-
thesia under the influence of drugs. In turn, auditory stimuli and
visual experiences were the most common inducers and concur-
rents, respectively. However, there is also considerable variability
across studies in the types of chemically-induced synaesthesias
reported by participants. The source of this variability is at present
unclear and may be driven by variability in the types of stim-
uli presented to participants and environment variability (most
studies were not conducted in controlled laboratory environ-
ments). The preponderance of sound and music as inducers is
likely due to the fact that participants commonly listen to music
whilst consuming drugs. A number of studies also report only
the prevalence of auditory-visual synaesthesias thereby inflating
the differential prevalence rates between this type and other types
of synaesthesia. Some phenomena labeled synaesthesia may actu-
ally be the result of other factors associated with the drug. For
instance, we have found examples where drug-induced halluci-
nations (e.g., Cooles, 1980) that lack an unequivocal inducer-
concurrent association pattern are incorrectly interpreted as
synaesthesias (Ballesteros et al., 2006; see also Terhune and Cohen
Kadosh, 2012). Finally, an increase in suggestibility following the
ingestion of psychedelic drugs (Whalley and Brooks, 2009) may
account for the occurrence of synaesthesia-like experiences that
appear to be the product of absorption.
A common critique of this literature is that drug-induced
synaesthesias tend to differ from congenital synaesthesias
(Hubbard and Ramachandran, 2003; Sinke et al., 2012) in terms
of the complexity and types of inducer-concurrent associations.
The present review only partly supports this conclusion. On the
one hand, there are reports of chemically-induced synaesthe-
sias with unusual inducer-concurrent associations that, to our
knowledge, have not been reported by congenital synaesthetes.
One striking example is Klüver’s (1966) report of a complex
visual-tactile-conceptual-visual-gustatory-olfactory synaesthesia
following the ingestion of mescaline. Similarly, we do not observe
any reports of particular well-documented types of synaesthe-
sia such as spatial-sequence synaesthesia (Cohen Kadosh et al.,
2012). On the other hand, there are examples of types of induced
synaesthesia that are well-documented in the literature includ-
ing grapheme-color (Brang and Ramachandran, 2008; Luke
et al., 2012) and auditory-color synaesthesias (e.g., Hartman and
Hollister, 1963). As an aside, we find it especially noteworthy
that auditory-visual is the most frequently reported drug-induced
synaesthesia as well as the most common acquired form of this
condition (Afra et al., 2009). The under-representation of specific
types of synaesthesia (e.g., grapheme-color, spatial-sequence)
may reflect a lack of exposure to alphanumeric stimuli during
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drug consumption or, alternatively, may suggest that such types
of synaesthesia require exposure to particular associations (e.g.,
Witthoft and Winawer, 2013) and/or take time to develop (e.g.,
Simner et al., 2009).
CRITERIA OF SYNAESTHESIA
An open question is whether chemically-induced synaesthesias
are equivalent to congenital synaesthesias. Consensus has yet to
emerge regarding the principal characteristics of synaesthesia and
the ways by which ostensible synaesthesias can be confirmed
as genuine. Nevertheless, there is considerable agreement that
inducer-concurrent associations are automatic, consistent, spe-
cific, and accessible to consciousness (Ward andMattingley, 2006;
Deroy and Spence, 2013; Ward, 2013; Terhune et al., 2014). Here
we use these criteria and other characteristics of congenital and
chemically-induced synaesthesias to briefly consider the extent to
which these two phenomena are similar.
Considered against these criteria, the available evidence indi-
cates that chemically-induced synaesthesias do not as yet qual-
ify as genuine synaesthesia. There is as yet no clear evidence
that chemically-induced synaesthesias are automatic as all stud-
ies to date have relied on self-report except for one study
(Brang and Ramachandran, 2008). The same goes for the cri-
teria of consistency and specificity. There is one study that
confirmed the consistency of melatonin-induced grapheme-color
synaesthesia (Brang and Ramachandran, 2008), which is sugges-
tive, but far from conclusive. The last criterion, accessibility to
consciousness, however, appears to be overwhelmingly met by
chemically-induced synaesthesias. These results clearly present a
mixed picture but it should be noted that almost none of the
studies have actually attempted to validate induced synaesthe-
sias. Accordingly, any strong judgments regarding the veracity of
chemically-induced synaesthesias in our opinion remain prema-
ture (for a different view, see Hochel and Milán, 2008).
Further evidence points to similarities and differences between
congenital and chemically-induced synaesthesias. As previously
noted, some researchers have emphasized that congenital synaes-
thesias tend to be relatively simple associations (Hubbard and
Ramachandran, 2003; Sinke et al., 2012) whereas induced
synaesthesias are often complex and sometimes reflect inducer-
concurrent associations not observed in congenital synaesthesia.
As observed in this review, there is considerable heterogeneity in
the types of chemically-induced synaesthesias. As noted above,
this variability may arise from different factors associated with
the respective drug and environmental influences. Although the
complexity and dynamism of psychedelic-induced synaesthesia
is evident in some reports (e.g., Klüver, 1966) it is not manda-
tory (e.g., Simpson and McKellar, 1955), and indeed as Sinke
et al. (2012) note, the complexity of the visual concurrent experi-
ence is related to dose and time from dosing (i.e., the intensity of
the drug experience). It is notable that grapheme-color synaes-
thesia, the most well-studied form of congenital synaesthesia,
was also reported by∼1% of recreational psychedelic tryptamine
(e.g., LSD, psilocybin) users in an online survey (Luke et al.,
2012). Furthermore, music and other auditory stimuli, the most
common inducers across the studies reviewed here, function as
inducers in more than 25% of cases of congenital synaesthesia
(Hochel and Milán, 2008) (see above). Other notable similarities
include individual differences in the visuospatial phenomenol-
ogy of color concurrents in chemically-induced (Klüver, 1966)
and congenital (Dixon et al., 2004; Ward et al., 2007) synaes-
thesias. Finally, the result that individuals high in absorption are
more prone to chemically-induced synaesthesias (Studerus, 2013)
is notable because absorption is indiscriminable from fantasy-
proneness (Rhue and Lynn, 1989) and the fantasizing component
of empathy is elevated among congenital synaesthetes (Banissy
et al., 2013). Thus, individuals who are prone to chemically-
induced synaesthesia may have a similar cognitive perceptual
personality profile as congenital synaesthetes. To summarize,
chemically-induced synaesthesias do not as yet meet accepted cri-
teria for genuine synaesthesia, although no study has attempted
to rigorously investigate this question. Induced synaesthesias do,
however, display a number of striking similarities to congenital
synaesthesias that warrant further attention.
FUTURE DIRECTIONS
The present review shows that there is convergent evidence that
particular chemical agents produce synaesthesia-like experiences.
However, the studies conducted to date suffer from numerous
limitations and many questions remain unaddressed. Here we
briefly outline further directions for research on the chemical
induction of synaesthesia.
Future research on chemically-induced synaesthesia will need
to utilize up-to-date methodologies to confirm that induced-
synaesthesias are not the product of demand characteristics.
In particular, there is a strong need for placebo-controlled,
double-blind studies of these phenomena. There is consistent
evidence that chemically-induced synaesthesias are more com-
mon with serotonin agonists, but experimental studies that
directly compare a range of chemical agents are required before
firm conclusions can be made. Future studies will also need
to include established measures to verify the occurrence of
synaesthesia such as measures of the automaticity (e.g., Dixon
et al., 2004) and consistency (Eagleman et al., 2007; Rothen
et al., 2013) of inducer-concurrent associations, rather than
relying solely on self-reports as is the norm in the studies to
date. Elsewhere, we have noted that some criteria (e.g., con-
sistency) may not be applicable to genuine synaesthesia at an
early stage because the associations may have yet to undergo
consolidation (Terhune et al., 2014). Specifically, consistency of
inducer-concurrent associations in congenital synaesthetes may
arise through a consolidation process wherein the inducer and
concurrent are repeatedly paired and the association is strength-
ened and becomes more specific over time. This hypothesis is
consistent with research showing that inducer-concurrent consis-
tency increases over time in children with synaesthesia (Simner
et al., 2009). This should be considered when assessing the verac-
ity of chemically-induced synaesthesias. Future studies would
also benefit from the inclusion of more comprehensive phe-
nomenological inventories in order to identify the similarities
and differences between congenital and induced synaesthesias.
Finally, it would be valuable to determine using transcranial mag-
netic stimulation whether drug-induced synaesthesias are depen-
dent upon similar cortical structures (e.g., parietal cortex) as
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congenital synaesthesias (Esterman et al., 2006; Muggleton et al.,
2007; Rothen et al., 2010). Pursuing these lines of investigation
will help to elucidate whether chemically-induced synaesthesias
are similar to congenital synaesthesias and thereby greatly inform
further research on the neurophysiological and neurochemi-
cal mechanisms underlying congenital and chemically-induced
synaesthesias.
SUMMARY AND CONCLUSIONS
Although it is nearly 170 years since the first report of the phar-
macological induction of synaesthesia (Gautier, 1843), research
on this topic remains in its infancy. There is consistent, and
convergent, evidence that a variety of chemical agents, partic-
ularly serotonergic agonists, produce synaesthesia-like experi-
ences, but the studies investigating this phenomenon suffer from
numerous limitations. The wide array of suggestive findings to
date are sufficiently compelling as to warrant future research
regarding the characteristics and mechanisms of chemically-
induced synaesthesias.
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